Ivacaftor Intermediates
Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis.
13721-01-2:
52980-28-6:
873055-58-4:
Specifications:
| Intermediate | CAS No’s | API/End Use | Status | Purity |
| Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | 52980-28-6 | Ivacaftor | Commercial | NLT 95% |
| 4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 13721-01-2 | Ivacaftor | Commercial | NLT 99% |
| 5-Amino-2,4-ditert-butylphenol | 873055-58-4 | Ivacaftor | Lab Scale | NLT 96% |